메뉴 건너뛰기




Volumn 8, Issue 4, 2011, Pages 376-379

Treating the systemic effects of chronic obstructive pulmonary disease claus

Author keywords

Chronic obstructive pulmonary disease; Comorbidities; Systemic effects; Systemic inflammation; Therapy

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GHRELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL SUCCINATE; NANDROLONE; PLACEBO; PRAVASTATIN; SIMVASTATIN; VITAMIN D;

EID: 80051774364     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201102-020RM     Document Type: Conference Paper
Times cited : (13)

References (34)
  • 1
    • 0036899028 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease. 5: Systemic effects of COPD
    • DOI 10.1136/thorax.57.12.1067
    • Wouters EFM. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax 2002;55:1067-1070. (Pubitemid 35440768)
    • (2002) Thorax , vol.57 , Issue.12 , pp. 1067-1070
    • Wouters, E.F.M.1
  • 3
    • 66749141807 scopus 로고    scopus 로고
    • Systemic manifestations and comorbidities of COPD
    • Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185.
    • (2009) Eur Respir J , vol.33 , pp. 1165-1185
    • Barnes, P.J.1    Celli, B.R.2
  • 5
    • 77956686967 scopus 로고    scopus 로고
    • Sputum neutrophils as a biomarker in COPD: Findings from the ECLIPSE study
    • Singh D, Edwards L, Tal-Singer R, Rennard S. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res 2010;15;11:77.
    • (2010) Respir Res , vol.15 , Issue.11 , pp. 77
    • Singh, D.1    Edwards, L.2    Tal-Singer, R.3    Rennard, S.4
  • 7
    • 42949160618 scopus 로고    scopus 로고
    • Possible mechanisms underlying the development of cachexia in COPD
    • Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2007;31:492-501.
    • (2007) Eur Respir J , vol.31 , pp. 492-501
    • Wagner, P.D.1
  • 8
    • 24944473849 scopus 로고    scopus 로고
    • Treatment of cachexia with ghrelin in patients with COPD
    • DOI 10.1378/chest.128.3.1187
    • Nagaya N, Itoh T, Murakami S, Oya H, Uematsu M, Miyatake K, Kangawa K. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005;128:1187-1193. (Pubitemid 41324394)
    • (2005) Chest , vol.128 , Issue.3 , pp. 1187-1193
    • Nagaya, N.1    Itoh, T.2    Murakami, S.3    Oya, H.4    Uematsu, M.5    Miyatake, K.6    Kangawa, K.7
  • 10
    • 73449124097 scopus 로고    scopus 로고
    • Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: A randomised controlled trial
    • van Wetering CR, Hoogendoorn M, Mol SJ, Rutten-van Mölken MP, Schols AM. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010;65:7-13.
    • (2010) Thorax , vol.65 , pp. 7-13
    • Van Wetering, C.R.1    Hoogendoorn, M.2    Mol, S.J.3    Rutten-van Mölken, M.P.4    Schols, A.M.5
  • 16
    • 30344488982 scopus 로고    scopus 로고
    • Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey
    • DOI 10.1378/chest.128.6.3792
    • Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 2005;128:3792-3798. (Pubitemid 43062638)
    • (2005) Chest , vol.128 , Issue.6 , pp. 3792-3798
    • Black, P.N.1    Scragg, R.2
  • 17
    • 0032552240 scopus 로고    scopus 로고
    • Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
    • DOI 10.1056/NEJM199808203390801
    • Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-497. (Pubitemid 28384881)
    • (1998) New England Journal of Medicine , vol.339 , Issue.8 , pp. 489-497
    • Gottlieb, S.S.1    McCarter, R.J.2    Vogel, R.A.3
  • 19
    • 77952694203 scopus 로고    scopus 로고
    • A curious case of beta-blockers in chronic obstructive pulmonary disease
    • Sin DD, Man SF. A curious case of beta-blockers in chronic obstructive pulmonary disease. Arch Intern Med 2010;170:849-850.
    • (2010) Arch Intern Med , vol.170 , pp. 849-850
    • Sin, D.D.1    Man, S.F.2
  • 21
    • 41849085549 scopus 로고    scopus 로고
    • Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
    • DOI 10.1136/thx.2007.081893
    • Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008;63:301-305. (Pubitemid 351497940)
    • (2008) Thorax , vol.63 , Issue.4 , pp. 301-305
    • Dransfield, M.T.1    Rowe, S.M.2    Johnson, J.E.3    Bailey, W.C.4    Gerald, L.B.5
  • 22
    • 73449091199 scopus 로고    scopus 로고
    • Pharmacological actions of statins: Potential utility in COPD
    • Young RP, Hopkins R, Eaton TE. Pharmacological actions of statins: potential utility in COPD. Eur Respir Rev 2009;18:222-232.
    • (2009) Eur Respir Rev , vol.18 , pp. 222-232
    • Young, R.P.1    Hopkins, R.2    Eaton, T.E.3
  • 23
    • 68349104141 scopus 로고    scopus 로고
    • Associations between statins and COPD: A systematic review
    • Dobler CC, Wong KK, Marks GB. Associations between statins and COPD: a systematic review. BMC Pulm Med 2009;9:32.
    • (2009) BMC Pulm Med , vol.9 , pp. 32
    • Dobler, C.C.1    Wong, K.K.2    Marks, G.B.3
  • 24
    • 33744994082 scopus 로고    scopus 로고
    • Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease
    • DOI 10.1016/j.jacc.2006.04.039, PII S0735109706011077
    • Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006;47:2554-2560. (Pubitemid 43866389)
    • (2006) Journal of the American College of Cardiology , vol.47 , Issue.12 , pp. 2554-2560
    • Mancini, G.B.J.1    Etminan, M.2    Zhang, B.3    Levesque, L.E.4    FitzGerald, J.M.5    Brophy, J.M.6
  • 25
    • 46349098873 scopus 로고    scopus 로고
    • Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease
    • van Gestel YR, Hoeks SE, Sin DD, Simsek C, Welten GM, Schouten O, Stam H, Mertens FW, van Domburg RT, Poldermans D. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol 2008;102: 192-196.
    • (2008) Am J Cardiol , vol.102 , pp. 192-196
    • Van Gestel, Y.R.1    Hoeks, S.E.2    Sin, D.D.3    Simsek, C.4    Welten, G.M.5    Schouten, O.6    Stam, H.7    Mertens, F.W.8    Van Domburg, R.T.9    Poldermans, D.10
  • 26
    • 38849125493 scopus 로고    scopus 로고
    • Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin
    • Lee TM, Lin MS, Chang NC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 2008;101:530-535.
    • (2008) Am J Cardiol , vol.101 , pp. 530-535
    • Lee, T.M.1    Lin, M.S.2    Chang, N.C.3
  • 29
    • 70350088412 scopus 로고    scopus 로고
    • The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity
    • Watz H, Waschki B, Kirsten A, Müller KC, Kretschmar G, eyer T, Holz O, Magnussen H. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009;136:1039-1046.
    • (2009) Chest , vol.136 , pp. 1039-1046
    • Watz, H.1    Waschki, B.2    Kirsten, A.3    Müller, K.C.4    Kretschmar, G.5    Eyer, T.6    Holz, O.7    Magnussen, H.8
  • 30
    • 47949104798 scopus 로고    scopus 로고
    • The role of exercise and PGC1alpha in inflammation and chronic disease
    • Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008;454:463-469.
    • (2008) Nature , vol.454 , pp. 463-469
    • Handschin, C.1    Spiegelman, B.M.2
  • 32
    • 77953255795 scopus 로고    scopus 로고
    • Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease
    • Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:1072-1077.
    • (2010) Am J Respir Crit Care Med , vol.181 , pp. 1072-1077
    • Troosters, T.1    Probst, V.S.2    Crul, T.3    Pitta, F.4    Gayan-Ramirez, G.5    Decramer, M.6    Gosselink, R.7
  • 33
    • 55949119252 scopus 로고    scopus 로고
    • Muscle as an endocrine organ: Focus on muscle-derived interleukin-6
    • Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008;88:1379-1406.
    • (2008) Physiol Rev , vol.88 , pp. 1379-1406
    • Pedersen, B.K.1    Febbraio, M.A.2
  • 34
    • 13444250953 scopus 로고    scopus 로고
    • The effects of a smoking cessation intervention on 14.5-year mortality: A randomized clinical trial
    • Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-239. (Pubitemid 40216240)
    • (2005) Annals of Internal Medicine , vol.142 , Issue.4 , pp. 233-239
    • Anthonisen, N.R.1    Skeans, M.A.2    Wise, R.A.3    Manfreda, J.4    Kanner, R.E.5    Connett, J.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.